Publication | Closed Access

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

Radiation TherapyHistone Deacetylase InhibitorPelvic RadiationMedicineGastrointestinal OncologyCancer TreatmentOncologyRadiation OncologyPhase 1RadiologyHealth Sciences